Cathie Wood's ARK Investment Management adjusted several exchange-traded fund holdings on June 3, adding to positions in Amazon.com (AMZN, Financials) and Advanced Micro Devices (AMD, Financials), while trimming stakes in CoreWeave (CRWV, Financials) and Palantir Technologies (PLTR, Financials).
Amazon saw a purchase of 29,837 shares worth approximately $6.17 million through the ARK Next Generation Internet ETF. The same fund added 53,081 shares of AMD valued at around $6.08 million.
ARKW also sold 108,281 shares of CoreWeave, totaling over $13 million. The ARK Innovation ETF (ARKK) offloaded 45,690 shares of Palantir worth roughly $6 million.
ARKK increased its stake in Guardant Health (GH, Financials) by acquiring 173,197 shares valued at about $7.29 million and bought 289,802 shares of 10X Genomics (TXG, Financials) for $2.74 million.
Other trades included the ARK Genomic Revolution ETF (ARKG) selling 64,769 shares of Adaptive Biotechnologies (ADPT, Financials) for $618,543. The ARK Fintech Innovation ETF (ARKF) purchased 25,447 shares of eToro Group (ETOR, Financials) valued at $1.56 million.
ARK sold 3,908 shares of CrowdStrike (CRWD, Financials), 7,800 shares of 3D Systems (DDD, Financials), and 100 shares of UiPath (PATH, Financials). ARKG also purchased 2,916 shares of Illumina (ILMN, Financials).
The moves indicate a shift in ARK's positioning toward selective healthcare and platform software names while continuing to pare down exposure to other growth tech stocks.
